Number of the records: 1
Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice
- 1.0325250 - MBÚ 2009 RIV CH eng C - Conference Paper (international conference)
Tomala, Jakub - Kovář, Marek - Chmelová, Helena - Strohalm, Jiří - Ulbrich, Karel - Říhová, Blanka
Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice.
[Součinný léčebný efekt imunokomplexů IL-2/anti-IL-2 protilátky a.]
Meeting of the International Society of Oncology and BioMarkers /36./. Basel: KARGER, 2008, s. 59-59. ISSN 1010-4283. E-ISSN 1423-0380.
[Meeting of the International Society of Oncology and BioMarkers /36./. Tokyo (JP), 05.10.2008-09.10.2008]
R&D Projects: GA ČR GP301/07/P192; GA MŠMT 1M0505
Institutional research plan: CEZ:AV0Z50200510; CEZ:AV0Z40500505
Keywords : doxorubicin * IL-2/anti-IL-2mAb * melanoma
Subject RIV: EC - Immunology
Therapeutics sinergistic influence of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin lwas studied. A it nas been shown it leads to significantly prolonged survival of mice
Naším cílem bylo blíže objasnit mechanismus účinku imunokomplexů IL-2/anti-IL-2 protilátky a zhodnotit jejich in vivo potenciál v kombinaci s polymerním doxorubicinovým konjugátem na buněčné linii B16F10 melanomu
Permanent Link: http://hdl.handle.net/11104/0172736
Number of the records: 1